Tumor Targeted Nanocarriers for Immunotherapy
The paramount discovery of passive accumulation of nanoparticles in tumoral tissues triggered the development of a wide number of different nanoparticles capable of transporting therapeutic agents to tumoral tissues in a controlled and selective way.These nanocarriers have been endowed with important capacities such as stimuli-responsive properties